Haemonetics 3rd Quarter Fiscal 2017 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Barrington Research Downgrades Haemonetics (HAE) to Market Perform
February 7, 2017 9:33 AM ESTBarrington Research downgraded Haemonetics (NYSE: HAE) from Outperform to Market Perform and removed its price target (prior $41.00).
For an analyst ratings summary and ratings history on Haemonetics click here. For more ratings news on Haemonetics click here.
Shares of Haemonetics closed at $38.00 yesterday.
... More